-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Novel Inhibitors of Transcriptional Mechanisms

Program: Scientific Program
Session: JOINT SESSION: Emerging Therapeutic Strategies Targeting Epigenetic, Transcriptomic, and Metabolic Mechanisms
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acute Myeloid Malignancies, AML, Translational Research, Diseases, Myeloid Malignancies
Sunday, December 8, 2024, 9:30 AM-11:05 AM

Hannah J Uckelmann, PhD

Frankfurt Cancer Institute, Frankfurt, Germany

Disclosures: No relevant conflicts of interest to declare.

See more of: JOINT SESSION: Emerging Therapeutic Strategies Targeting Epigenetic, Transcriptomic, and Metabolic Mechanisms
See more of: Scientific Program
Previous Presentation | Next Presentation >>